Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV‐associated disease after bone marrow transplantation

British Journal of Haematology

Volumn 86, Issue 1, 1994, Pages 130-137

  Gondo, Hisashi ^a,c   Minematsu, Toshio ^a,b   Harada, Mine ^a   Akashi, Koichi ^a,c   Hayashi, Shin ^a,c   Taniguchi, Shuichi ^a,d   Yamasaki, Kazuo ^a,d   Shibuya, Tsunefumi ^a,d   Takamatsu, Yasushi ^a   Teshima, Takanori ^a   Eto, Tetsuya ^a   Nagafuji, Koji ^a   Mizuno, Shin‐ichi ^a   Hosoda, Kenji ^a,e   Mori, Ryoichi ^a   Minamishima, Yoichi ^a,b   Niho, Yoshiyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c HARASANSHIN HOSPITAL   (Japan)

^d HAMANOMACHI HOSPITAL   (Japan)

^e Teijin ^*  (Japan)

Author keywords

antigenaemia; bone marrow transplantation; cytomegalovirus

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; GANCICLOVIR; IMMUNOGLOBULIN; MELPHALAN; METHOTREXATE; VIRUS ANTIGEN;

ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BLOOD LEVEL; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CYTOMEGALOVIRUS; FEMALE; GRAFT REJECTION; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; LEUKOCYTE; LYMPHOMA; MALE; PRIORITY JOURNAL; VIRUS INFECTION;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIGENS, VIRAL; BONE MARROW TRANSPLANTATION; CASE REPORT; CYSTITIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT VS HOST DISEASE; HEMORRHAGE; HUMAN; IMMUNOENZYME TECHNIQUES; LEUKOCYTES; MALE; TIME FACTORS;

EID: 0028303991     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1994.tb03263.x     Document Type: Article

References (30)

1. Prophylactic use of ganciclovir in allogeneic bone marrow transplantation; absence of clinical cytomegalovirus infection
2. Rapid diagnosis of cytomegalovirus infections by direct immunoperoxidase staining with human monoclonal antibody against an immediate‐early antigen
3. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high‐dose intravenous immune globulin
4. Progress in the treatment of cytomegalovirus pneumonia
5. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins
6. Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft‐versus‐host disease
7. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation
8. Necrotizing tubulointerstitial nephritis associated with adenovirus infection
9. Cytomegalovirus infections in organ transplantation and post transfusion. A hypothesis
10. Risk factors for cytomegalovirus infection after human marrow transplantation
11. Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia
12. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft‐vs‐host disease
13. Low incidence of acute graft‐versus‐host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity
14. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants
15. Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viremia in immunocompromised patients
16. Viral infections and graft‐vs‐host disease
17. Treatment of CMV infections and disease in transplantation
18. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants
19. Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus‐associated interstitial pneumonia in bone marrow allograft recipients
20. Adenovirus infections in patients undergoing bone‐marrow transplantation
21. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft‐versus‐host disease after marrow transplantation for leukemia
22. Interstitial pneumonitis in allogeneic bone marrow transplantation: a report from the Japanese BMT study group
23. Cytomegalovirus antigenemia
24. Bone‐marrow transplantation
25. Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation—a report of 130 consecutive patients
26. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood
27. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes
28. Cytomegalovirus (CMV) antigenemia: rapid diagnosis and relationship with CMV‐associated clinical syndromes in renal allograft recipients
29. Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients
30. Infections